UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Nutanix, Inc. (NASDAQ:NTNX - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 886,338 shares of the technology company's stock after purchasing an additional 29,241 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.33% of Nutanix worth $52,516,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in NTNX. Cetera Investment Advisers increased its holdings in Nutanix by 48.7% in the 1st quarter. Cetera Investment Advisers now owns 76,103 shares of the technology company's stock worth $4,697,000 after acquiring an additional 24,918 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Nutanix by 35.2% during the 2nd quarter. GAMMA Investing LLC now owns 933 shares of the technology company's stock worth $53,000 after purchasing an additional 243 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Nutanix in the 2nd quarter valued at about $25,000. CWM LLC lifted its stake in Nutanix by 39.8% in the 2nd quarter. CWM LLC now owns 11,664 shares of the technology company's stock valued at $663,000 after buying an additional 3,323 shares in the last quarter. Finally, Symmetry Partners LLC boosted its holdings in Nutanix by 19.5% in the 2nd quarter. Symmetry Partners LLC now owns 7,831 shares of the technology company's stock worth $445,000 after buying an additional 1,279 shares during the last quarter. 85.25% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research firms have recently weighed in on NTNX. Wells Fargo & Company raised their target price on Nutanix from $60.00 to $75.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 27th. Royal Bank of Canada lifted their target price on shares of Nutanix from $70.00 to $75.00 and gave the stock an "outperform" rating in a research note on Thursday, August 29th. Barclays increased their target price on shares of Nutanix from $75.00 to $87.00 and gave the company an "overweight" rating in a research report on Wednesday, November 27th. Needham & Company LLC boosted their price target on shares of Nutanix from $80.00 to $90.00 and gave the stock a "buy" rating in a research report on Wednesday, November 27th. Finally, Piper Sandler increased their price objective on shares of Nutanix from $77.00 to $83.00 and gave the company an "overweight" rating in a report on Wednesday, November 27th. Three analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Nutanix presently has an average rating of "Moderate Buy" and a consensus target price of $78.86.
Read Our Latest Analysis on NTNX
Nutanix Stock Performance
Shares of Nutanix stock traded up $2.01 during trading hours on Wednesday, reaching $68.02. 1,793,429 shares of the company were exchanged, compared to its average volume of 2,582,137. The firm has a market cap of $18.04 billion, a PE ratio of -188.60, a PEG ratio of 10.40 and a beta of 1.13. The stock's fifty day moving average is $65.09 and its 200 day moving average is $59.28. Nutanix, Inc. has a 1 year low of $43.35 and a 1 year high of $75.80.
Insider Transactions at Nutanix
In related news, COO David Sangster sold 11,950 shares of Nutanix stock in a transaction on Monday, September 16th. The shares were sold at an average price of $59.83, for a total transaction of $714,968.50. Following the sale, the chief operating officer now directly owns 123,868 shares in the company, valued at $7,411,022.44. This trade represents a 8.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Rukmini Sivaraman sold 24,316 shares of the company's stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $58.85, for a total transaction of $1,430,996.60. Following the completion of the transaction, the chief financial officer now owns 192,169 shares of the company's stock, valued at $11,309,145.65. This represents a 11.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 6.80% of the company's stock.
Nutanix Profile
(
Free Report)
Nutanix, Inc provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. The company offers hyperconverged infrastructure software stack that converges virtualization, storage, and networking services into a turnkey solution; Acropolis Hypervisor, an enterprise-grade virtualization solution; flow virtual networking and flow network security, which offers services to visualize the network, automate common network operations, and build virtual private networks; Nutanix Kubernetes Engine for automated deployment and management of Kubernetes clusters to simplify the provisioning, operations, and lifecycle management of cloud-native environments, applications, and microservices; and Nutanix Cloud Clusters.
Recommended Stories
Before you consider Nutanix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutanix wasn't on the list.
While Nutanix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.